Capricor Therapeutics, Inc. (CAPR)

34.70 +0.11 (+0.32%) USD  |  NASDAQ  |  Apr 17, 16:00
34.76 +0.06 (+0.17%) Pre-Market: 20:00
More

Capricor Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for CAPR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Inovio Pharmaceuticals, Inc. Upgrade
Repligen Corp. Upgrade
Vaxart, Inc. Upgrade
Penumbra, Inc. Upgrade
Allogene Therapeutics, Inc. --